ASN
XBIT icon

Advisory Services Network’s XBiotech XBIT Stock Holding History

Advisory Services Network’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-200
Closed -$3K – 3247
2021
Q2 		$3K Buy
+200
New +$3.39K ﹤0.01% 3257
2021
Q1 		– Sell
-200
Closed -$3K – 2968
2020
Q4 		$3K Hold
200
– – ﹤0.01% 2940
2020
Q3 		$4K Buy
+200
New +$3.45K ﹤0.01% 2881

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Advisory Services Network's XBIT Position: Q3 2021 in Review

Advisory Services Network sold out of XBiotech (XBIT) in Q3 2021, closing a stake of 200 shares — an estimated $3K sold.

Advisory Services Network first reported a position in XBIT in Q3 2020 and held it in 3 quarters. The position peaked at $4K in Q3 2020. 66 funds tracked by Wall St. Rank hold XBIT as of Q3 2021.

  • Advisory Services Network reported no remaining XBiotech position as of Q3 2021 after selling out during the quarter.
  • Advisory Services Network sold 200 XBiotech shares in Q3 2021, an estimated $3K.
  • Advisory Services Network first reported a position in XBiotech in Q3 2020 and held it in 3 quarters.
  • Advisory Services Network's XBiotech position peaked at $4K in Q3 2020.
  • 66 funds tracked by Wall St. Rank held XBiotech as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.